scholarly journals 104P Exploring the real-world impact of COVID-19 on first line (1L) treatment and management of EGFR-wild type (EGFR-WT) and ALK-wild type (ALK-WT) metastatic non-small cell lung cancer (mNSCLC) across Europe

2021 ◽  
Vol 32 ◽  
pp. S1420
Author(s):  
H. Bailey ◽  
A. Lee ◽  
L. Eccles ◽  
Y. Yuan ◽  
M. Last ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Wild Type ◽  
Small Cell Lung ◽  
First Line ◽  
The Real

scholarly journals First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

2021 ◽  
Author(s):  
Martina Lorenzi ◽  
Alessandra Ferro ◽  
Fabiana Cecere ◽  
Daniela Scattolin ◽  
Alessandro Del Conte ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
The Real ◽  
Cancer Outcome ◽  
Egfr Mutant

scholarly journals Real-world survival with first-line (1L) chemotherapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

2019 ◽  
Vol 30 ◽  
pp. xi29-xi30
Author(s):  
D. Waterhouse ◽  
K.A. Betts ◽  
J. Zhao ◽  
S. Rao ◽  
K. Gupte-Singh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document